CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.

Bruce Ruggeri, Craig A. Dionne, Susan Jones‐Bolin et al.|PubMed|2003

Cited by 124